GridAI Technologies (GRDX) Other financing activities (2016 - 2026)
GridAI Technologies' (GRDX) quarterly Other financing activities came in at $148853.0 in Q2 2026, down 91.4% quarter-over-quarter from $1.7 million in Q3 2024.
Analysis
GridAI Technologies (GRDX) Other financing activities (2016 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Other financing activities for 10 consecutive years, with $148853.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other financing activities changed N/A year-over-year to $148853.0; the trailing twelve-month figure through Jun 2026 stood at $1.9 million (changed N/A YoY), and the FY2025 full-year result was $166448.0, changed N/A from the prior year.
- Other financing activities fell to $148853.0 in Q2 2026 per GRDX's latest filing, from $1.7 million in the prior quarter.
- Across five years, Other financing activities topped out at $7.6 million in Q3 2022 and bottomed at -$1.0 in Q4 2022.
- Historically, Other financing activities has averaged $1.8 million across 4 years, with a median of $148853.0 in 2026.
- The sharpest annual moves came in 2022 and 2023: Other financing activities sank 100.0% in 2022, then jumped 435827600.0% in 2023.
- Over 4 years, Other financing activities stood at -$1.0 in 2022, then surged by 435827600.0% to $4.4 million in 2023, then sank by 60.3% to $1.7 million in 2024, then sank by 91.4% to $148853.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $148853.0, $1.7 million, and $36.0 for Q2 2026, Q3 2024, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 148,853.00 |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 36.00 |
| Mar 31, 2024 | 9.00 |
| Dec 31, 2023 | 4.36 Mn |
| Sep 30, 2023 | 3.71 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 301.00 |
| Dec 31, 2022 | -1.00 |
| Sep 30, 2022 | 7.64 Mn |
| Mar 31, 2022 | 48,482.00 |
| Dec 31, 2021 | 10.18 Mn |
| Sep 30, 2021 | 3.42 Mn |
| Jun 30, 2021 | 282,788.00 |
| Mar 31, 2021 | 4.62 Mn |
| Sep 30, 2020 | -5,000.00 |
| Jun 30, 2020 | 5,000.00 |
| Dec 31, 2019 | -1.74 Mn |
| Mar 31, 2019 | 1.74 Mn |
| Dec 31, 2018 | 1.32 Mn |